首页|冠心病患者血清脂联素、脂蛋白相关磷脂酶A2、同型半胱氨酸水平及临床意义

冠心病患者血清脂联素、脂蛋白相关磷脂酶A2、同型半胱氨酸水平及临床意义

扫码查看
目的 探究冠心病患者血清脂联素、脂蛋白相关磷脂酶A2(LP-PLA2)、同型半胱氨酸(HCY)水平变化特征,分析其与冠心病的关系,为临床诊断和治疗提供可靠的参考指标.方法 选择2022 年4 月至2023 年4 月收治的180 例冠心病患者作为冠心病组,采集其血清样本进行脂联素、LP-PLA2、HCY水平检测,并与80 例体检健康者(对照组)进行比较分析.同时冠心病患者按照疾病严重程度分为急性心肌梗死(AMI)组111 例、不稳定型心绞痛(UAP)组58 例、慢性稳定型心脏病(SAP)组11 例,并对比各组上述血清指标差异,采用Spearmen相关性分析探究脂联素、LP-PLA2、HCY水平与冠心病进展的关系.结果 冠心病组血清脂联素低于对照组,血清HCY、LP-PLA2 高于对照组(P<0.01).冠心病患者治疗后血清LP-PLA2、HCY水平均较治疗前降低,脂联素水平较治疗前升高(P<0.01).AMI、UAP组患者脂联素水平低于SAP组,AMI组脂联素水平低于UAP组(P<0.05).AMI、UAP组患者LP-PLA2、HCY水平高于SAP组,AMI组LP-PLA2、HCY水平高于UAP组(P<0.05).Spearmen相关性分析显示,血清脂联素与冠心病进展呈负相关关系(r=-0.705,P<0.01),LP-PLA2、HCY与冠心病进展呈正相关关系(r=0.537、0.621,P<0.01).结论 冠心病患者血清脂联素降低及LP-PLA2、HCY水平异常升高与冠心病严重程度密切相关,其可以作为冠心病辅助诊断和预测指标.脂联素、LP-PLA2、HCY水平检测对冠心病的早期诊断和危险评估具有重要意义.
Serum Adiponectin,LP-PLA2,HCY Levels and Their Clinical Signifi-cance in Patients with Coronary Heart Disease
Objective To explore the change characteristics of serum adiponectin,lipoprotein-associated phospho-lipase A2(LP-PLA2)and homocysteine(HCY)levels in patients with coronary heart disease(CHD),and analyze their re-lationship with CHD,so as to provide a reliable reference index for clinical diagnosis and treatment.Methods 180 patients with CHD treated from April 2022 to April 2023 were selected as the CHD group.Adiponectin,LP-PLA2 and HCY levels of serum samples were detected,and compared with 80 healthy subjects(control group).Meanwhile,CHD patients were divid-ed into acute myocardial infarction(AMI)group 111 cases,unstable angina pectoris(UAP)group 58 cases and chronic sta-ble heart disease(SAP)group 11 cases according to the severity of the disease.Spearmen correlation analysis was used to in-vestigate the relationship between adiponectin,LP-PLA2 and HCY levels and the progression of coronary heart disease.Re-sults Serum adiponectin in CHD group was lower than control group,serum HCY and LP-PLA2 were higher than control group(P<0.01).The levels of serum LP-PLA2 and HCY in CHD patients after treatment were lower than those before treat-ment,and the levels of adiponectin were increased(P<0.01).The adiponectin level in AMI and UAP groups was lower than that in SAP group,and the adiponectin level in AMI group was lower than that in UAP group(P<0.05).The levels of LP-PLA2 and HCY in AMI and UAP groups were higher than those in SAP group,and the levels of LP-PLA2 and HCY in AMI group were higher than those in UAP group(P<0.05).Spearmen correlation analysis showed that serum adiponectin was negatively correlated with the progression of CHD(r=-0.705,P<0.01),and LP-PLA2 and HCY were positively correla-ted with the progression of CHD(r=0.537,0.621,P<0.01).Conclusion The decrease of serum adiponectin and the ab-normal increase of LP-PLA2 and HCY levels in patients with CHD are closely related to the severity of CHD,which can be used as an auxiliary diagnosis and prediction index of CHD.The levels of adiponectin,LP-PLA2 and HCY are important for the early diagnosis and risk assessment of coronary heart disease.

Coronary heart diseaseAdiponectinLipoprotein-associated phospholipase A2HomocysteineClinical significance

申辽辽、申文文、刘雅静、王敏

展开 >

719000 陕西榆林,西安交通大学第一附属医院榆林医院检验科

727000 陕西铜川,铜川矿务局中心医院检验科

710201 西安,西安宝石花长庆医院(长庆油田职工医院)检验科

712046 陕西咸阳,陕西中医药大学

展开 >

冠心病 脂联素 脂蛋白相关磷脂酶A2 同型半胱氨酸 临床意义

2024

转化医学杂志
海军总医院

转化医学杂志

CSTPCD
影响因子:0.671
ISSN:2095-3097
年,卷(期):2024.13(8)